Cubist Pharmaceuticals, Inc. was an American biopharmaceutical company that focused on the research, development, and commercialization of pharmaceutical products targeting pathogens like MRSA. The company was acquired by Merck & Co. in 2015.
Focus Areas
Notable Investments
